Inventor
RALPH DAVID A
US10 patents
Patents
10 patentsUS11007272B1May 18, 2021
Compounds and methods for diagnosis and treatment of viral infections
NAVIDEA BIOPHARMACEUTICALS INC6 citations81
US11833170B2Dec 5, 2023
Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking
NAVIDEA BIOPHARMACEUTICALS INC2 citations67
US12583945B2Mar 24, 2026
Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof
NAVIDEA BIOPHARMACEUTICALS INC0 citations60
US11859023B2Jan 2, 2024
Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof
NAVIDEA BIOPHARMACEUTICALS INC0 citations60
US12005122B2Jun 11, 2024
Compounds and methods for diagnosis and treatment of viral infections
NAVIDEA BIOPHARMACEUTICALS INC0 citations59
US11590236B2Feb 28, 2023
Compositions and methods for altering macrophage phenotype
NAVIDEA BIOPHARMACEUTICALS INC1 citations59
US12404349B2Sep 2, 2025
Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers
NAVIDEA BIOPHARMACEUTICALS INC0 citations57
US12297222B2May 13, 2025
CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker
NAVIDEA BIOPHARMACEUTICALS INC0 citations57
US12178829B2Dec 31, 2024
Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking
NAVIDEA BIOPHARMACEUTICALS INC0 citations57
US12006339B2Jun 11, 2024
CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker
NAVIDEA BIOPHARMACEUTICALS INC0 citations57